Author:
Navab Mohamad,Chattopadhyay Arnab,Hough Greg,Meriwether David,Fogelman Spencer I.,Wagner Alan C.,Grijalva Victor,Su Feng,Anantharamaiah G.M.,Hwang Lin H.,Faull Kym F.,Reddy Srinivasa T.,Fogelman Alan M.
Subject
Cell Biology,Endocrinology,Biochemistry
Reference70 articles.
1. Searching for a successful HDL-based treatment strategy;Reddy;Biochim. Biophys. Acta.,2014
2. Structure and function of HDL mimetics;Navab;Arterioscler. Thromb. Vasc. Biol.,2010
3. Safety, pharmacokinetics, and pharmacodynamics of oral apoA-I mimetic peptide D-4F in high-risk cardiovascular patients;Bloedon;J. Lipid Res.,2008
4. Daily oral administration of the apolipoprotein A-I mimetic peptide D-4F in patients with coronary heart disease or equivalent risk improves high-density lipoprotein anti-inflammatory function (Abstract);Dunbar;J. Am. Coll. Cardiol.,2007
5. Treatment of patients with cardiovascular disease with L-4F, an apoA-1 mimetic, did not improve select biomarkers of HDL function;Watson;J. Lipid Res.,2011
Cited by
45 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献